American Resources Corp (NASDAQ:AREC), through its holding in ReElement Technologies, announced it has developed commercial protocols to produce germanium with purities exceeding 99.9% from both recycled and ore-based feedstocks. The company's process is designed to supply commercial and defense markets requiring germanium products with purities ranging from 99.9% to 99.999%.
American Resources Corp (NASDAQ:AREC) and its subsidiary ReElement Technologies has welcomed a newly announced cooperation agreement between the US and the Cook Islands to advance scientific research and the responsible development of seabed mineral resources. The bilateral initiative aims to promote sustainable economic development and strengthen U.S.-linked commercial activity in the Pacific region.
American Resources Corp (NASDAQ:AREC) CEO Mark Jensen talked with Proactive about the company's latest strategic step forward through its subsidiary, ReElement Technologies. He outlined a new agreement stemming from its existing partnership with Impossible Metals, with plans now underway to deploy refining technology in American Samoa.
The global race for critical minerals is accelerating amid rising geopolitical tension between the US and China. At the heart of this contest is access to rare earth elements—essential to everything from electric vehicles and fighter jets to data centers and missile guidance systems.
American Resources Corp (NASDAQ:AREC) and its subsidiary ReElement Technologies have signed a memorandum of understanding (MOU) with the American Samoa Economic Development Authority (ASEDA) to explore the development of a critical mineral refinery in the U.S. territory, the company said on Wednesday.
American Resources Corp (NASDAQ:AREC) earlier this week discussed a memorandum of understanding with Impossible Metals, a company focused on seabed nodule collection technology. The nodules contain critical minerals such as copper, cobalt, nickel, manganese, and rare earth elements.
American Resources Corp (NASDAQ:AREC) said its rare earth and critical mineral refining subsidiary, ReElement Technologies, has added several new hires. The company named David Appy as principal research scientist, Alexis Thomas as a materials lab technician, and Rhett Rezendes as a government affairs intern.
American Resources Corp (NASDAQ:AREC) said its subsidiaries ReElement Technologies and Electrified Materials have entered a strategic partnership with Blackion LLC to build a vertically integrated, domestic lithium-ion battery recycling supply chain in the US. The collaboration includes a recycling services agreement between Electrified Materials and Blackion, as well as a memorandum of understanding between ReElement and Blackion.
American Resources Corp (NASDAQ:AREC) and its subsidiary ReElement Technologies have signed a memorandum of understanding (MOU) with Impossible Metals Inc to jointly develop a vertically integrated US-based supply chain for critical minerals, the companies said on Monday. The partnership aims to combine Impossible Metals' deep-sea nodule harvesting technology with ReElement's refining capabilities to deliver copper, cobalt, nickel, manganese, and rare earth elements from seabed to finished product within the US.
American Resources Corp (NASDAQ:AREC) CEO Mark Jenses outlined progress earlier this week in its rare earth refining operations and expansion plans. The company owns a 19% stake in ReElement Technologies Corporation, which is refining critical and rare earth elements at costs it described as comparable to Chinese producers.
AREC expands refining deal with ReElement, targeting more than $29 million in annual revenues from U.S. defense and commercial markets.
Shares in Arecor Therapeutics PLC (AIM:AREC) rose 10% in morning trading after the company announced a new development deal with US biotech group Skye Bioscience to improve the formulation of a mid-stage obesity drug. The Cambridge-based firm will apply its proprietary Arestat technology to create a more concentrated version of nimacimab, a monoclonal antibody that targets the CB1 receptor, which plays a role in appetite and metabolism.